Crossref
Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval
Journal of Cutaneous Oncology · 2024
DOI: 10.59449/joco.2024.05.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Oncology, 2024. Verfasst von Jennifer Strong und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Strong, J., Miller, D., & Isaac, B. (2024). Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval. Journal of Cutaneous Oncology. https://doi.org/10.59449/joco.2024.05.01
Vancouver
Strong J, Miller D, Isaac B. Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval. Journal of Cutaneous Oncology. 2024. doi:10.59449/joco.2024.05.01
BibTeX
@article{Strong2024,
author = {Strong, Jennifer and Miller, David and Isaac, Brownell},
title = {Tumor-Infiltrating Lymphocyte Therapy Receives FDA Approval},
journal = {Journal of Cutaneous Oncology},
year = {2024},
doi = {10.59449/joco.2024.05.01}
}
EUVIMED